Aims and scope
Thorax is one of the world's leading respiratory medicine journals publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax is one of the highest ISI ranked journals covering all aspects of pulmonary medicine. Each issue covers topics such as COPD, asthma, smoking, respiratory infection and lung cancer; and includes editorials, short papers, review series, case reports, images in thorax, and letters.
Thorax is the official journal of the British Thoracic Society (BTS).
Thorax is co-owned by the British Thoracic Society (BTS) and BMJ Group.
|Acceptance rate||12% for original research submitted in 2012|
|Time from acceptance to publication||
22 days (online)
4 months (print)
|Indexed by||Index Medicus (Medline), Science Citation Index, ISI Current Contents (Clinical Medicine/Life Sciences), Excerpta Medica (Embase), BIOSIS Previews|
|ISSN of Thorax||0040-6376|
|ISSN of Thorax Online||1468-3296|
For all contact information please refer to the Contact Us page.
Please refer to the Instructions for Authors
Rights and permissions
- Thorax is provided as a benefit to members of the British Thoracic Society (BTS)
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.